REFERENCES
1. Aigner T, Stove J. Collagens--major component of the physiological cartilage matrix, major target of cartilage degeneration, major tool in cartilage repair. Adv Drug Deliv Rev 2003;55:1569-93.
2. Mow VC, Setton LA. Mechanical properties of normal and osteoarthritic articular cartilage. In: Brandt KD, Doherty M, Lohmander LS, editors. Osteoarthritis. Oxford: Oxford University Press; 1998. pp. 108-22.
3. Mauck LR, Burdick JA. Engineering cartilage tissue. In: Pallua N, Suschek CV, editors. Tissue Engineering, from lab to clinic. UK: Springer-Verlag Berlin Heidelberg; 2011. pp. 493-520.
4. Bastiaansen-Jenniskens YM, Koevoet W, de Bart AC, van der Linden JC, Zuurmond AM, et al. Contribution of collagen network features to functional properties of engineered cartilage. Osteoarthritis Cartilage 2008;16:359-66.
6. Kotlarz H, Gunnarsson CL, Fang H, Rizzo JA. Insurer and out-of-pocket costs of osteoarthritis in the US: evidence from national survey data. Arthritis Rheum 2009;60:3546-53.
7. Fransen M, Bridgett L, March L, Hoy D, Penserga E, et al. The epidemiology of osteoarthritis in Asia. Int J Rheum Dis 2011;14:113-21.
9. Jo CH, Chai JW, Jeong EC, Oh S, Shin JS, et al. Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the Knee: a 2-year follow-up study. Am J Sports Med 2017;45:2774-83.
10. Saklatvala J. Tumour necrosis factor alpha stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature 1986;322:547-9.
11. Lefebvre V, Peeters-Joris C, Vaes G. Modulation by interleukin 1 and tumor necrosis factor alpha of production of collagenase, tissue inhibitor of metalloproteinases and collagen types in differentiated and dedifferentiated articular chondrocytes. Biochim Biophys Acta 1990;22:366-78.
12. Kaneko S, Satoh T, Chiba J, Ju C, Inoue K, et al. Interleukin-6 and interleukin-8 levels in serum and synovial fluid of patients with osteoarthritis. Cytokines Cell Mol Ther 2000;6:71-9.
13. Sokolove J, Lepus CM. Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations. Ther Adv Musculoskelet Dis 2013;5:77-94.
14. Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier JP, Fahmi H. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol 2011;7:33-42.
15. Harris DJ, Flanigan DC. Management of knee articular cartilage injuries. In: Dragoo JL, editor. Modern Arthroscopy. InTech; 2011. pp. 103-28.
16. Bhatia D, Bejarano T, Novo M. Current interventions in the management of knee osteoarthritis. J Pharm Bioallied Sci 2013;5:30-8.
17. Jones IA, Togashi R, Wilson ML, Heckmann N, Vangsness CT Jr. Intra-articular treatment options for knee osteoarthritis. Nat Rev Rheumatol 2019;15:77-90.
18. Rabago D, Patterson JJ, Mundt M, Kijowski R, Grettie J, et al. Dextrose prolotherapy for knee osteoarthritis: a randomized controlled trial. Ann Fam Med 2013;11:229-37.
19. Glynn LG, Mustafa A, Casey M, Krawczyk J, Blom J, et al. Platelet-rich plasma (PRP) therapy for knee arthritis: a feasibility study in primary care. Pilot Feasibility Stud 2018;4:93.
20. Mancuso P, Raman S, Glynn A, Barry F, Murphy JM. Mesenchymal stem cell therapy for osteoarthritis: the critical role of the cell secretome. Front Bioeng Biotechnol 2019;7:9.
21. Case JM, Scopp JM. Treatment of articular cartilage defects of the knee with microfracture and enhanced microfracture techniques. Sports Med Arthrosc Rev 2016;24:63-8.
22. Inderhaug E, Solheim E. Osteochondral autograft transplant (mosaicplasty) for knee articular cartilage defects. JBJS Essent Surg Tech 2019;9:e34.1-2.
23. Kim MK, Park JS, Jeon YM, Jeon YS. Clinical, radiological, and histological outcomes after the fibrin-matrix autologous chondrocyte implantation for chondral lesions of the knee in patients more than 50 years old: a prospective case series with minimum 2-year follow-up. J Orthop Surg (Hong Kong) 2020;28:2309499019893509.
24. Erickson BJ, Strickland SM, Gomoll AH. Indications, techniques, outcomes for matrix-induced autologous chondrocyte implantation (MACI). Oper Tech Sports Med 2018;26:175-82.
25. Pers YM, Ruiz M, Noel D, Jorgensen C. Mesenchymal stem cells for the management of inflammation in osteoarthritis: state of the art and perspectives. Osteoarthritis Cartilage 2015;23:2027-35.
26. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy 2006;8:315-7.
27. Gupta PK, Das AK, Chullikana A, Majumdar AS. Mesenchymal stem cells for cartilage repair in osteoarthritis. Stem Cell Res Ther 2012;3:25.
28. Chen YC, Chen CH, Chen PL, Huang IY, Shen YS, et al. Donor site morbidity after harvesting of proximal tibia bone. Head Neck 2006;28:496-500.
29. Cotter EJ, Wang KC, Yanke AB, Chubinskaya S. Bone marrow aspirate concentrate for cartilage defects of the knee: from bench to bedside evidence. Cartilage 2018;9:161-70.
30. Nathan S, Das De S, Thambyah A, Fen C, Goh J, et al. Cell-based therapy in the repair of osteochondral defects: a novel use for adipose tissue. Tissue Eng 2003;9:733-44.
31. Si Z, Wang X, Sun C, Kang Y, Xu J, et al. Adipose-derived stem cells: Sources, potency, and implications for regenerative therapies. Biomed Pharmacother 2019;114:108765.
32. Baer PC, Geiger H. Adipose-derived mesenchymal stromal/stem cells: tissue localization, characterization, and heterogeneity. Stem Cells Int 2012;2012:812693.
33. Pak J, Lee JH, Park KS, Park M, Kang LW, et al. Current use of autologous adipose tissue-derived stromal vascular fraction cells for orthopedic applications. J Biomed Sci 2017;24:9.
34. De Ugarte DA, Morizono K, Elbarbary A, Alfonso Z, Zuk PA, et al. Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs 2003;174:101-9.
35. Xu L, Liu Y, Sun Y, Wang B, Xiong Y, et al. Tissue source determines the differentiation potentials of mesenchymal stem cells: a comparative study of human mesenchymal stem cells from bone marrow and adipose tissue. Stem Cell Res Ther 2017;8:275.
36. Heo JS, Choi Y, Kim HS, Kim HO. Comparison of molecular profiles of human mesenchymal stem cells derived from bone marrow, umbilical cord blood, placenta and adipose tissue. Int J Mol Med 2016;37:115-25.
37. Deng M, Gu Y, Liu Z, Qi Y, Ma GE, et al. Endothelial differentiation of human adipose-derived stem cells on polyglycolic acid/polylactic acid mesh. Stem Cells Int 2015;2015:350718.
38. Lin J, Zhu Q, Huang J, Cai R, Kuang Y. Hypoxia promotes vascular smooth muscle cell (VSMC) differentiation of adipose-derived stem cell (ADSC) by regulating mettl3 and paracrine factors. Stem Cells Int 2020;2020:2830565.
39. Edwards NJ, Stone R, Christy R, Zhang CK, Pollok B, et al. Differentiation of adipose derived stem cells to keratinocyte-like cells on an advanced collagen wound matrix. Tissue Cell 2018;53:68-75.
40. Wada Y, Ikemoto T, Morine Y, Imura S, Saito Y, et al. The differences in the characteristics of insulin-producing cells using human adipose-tissue derived mesenchymal stem cells from subcutaneous and visceral tissues. Sci Rep 2019;9:13204.
41. Gao S, Guo X, Zhao S, Jin Y, Zhou F, et al. Differentiation of human adipose-derived stem cells into neuron/motoneuron-like cells for cell replacement therapy of spinal cord injury. Cell Death Dis 2019;10:597.
42. Tomita K, Madura T, Sakai Y, Yano K, Terenghi G, et al. Glial differentiation of human adipose-derived stem cells: implications for cell-based transplantation therapy. Neuroscience 2013;236:55-65.
43. Lee RH, Kim B, Choi I, Kim H, Choi HS, et al. Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem 2004;14:311-24.
44. Tsuji W, Rubin JP, Marra KG. Adipose-derived stem cells: implications in tissue regeneration. World J Stem Cells 2014;6:312-21.
45. Sakaguchi Y, Sekiya I, Yagishita K, Muneta T. Comparison of human stem cells derived from various mesenchymal tissues - Superiority of synovium as a cell source. Arthritis Rheum 2005;52:2521-9.
46. Mochizuki T, Muneta T, Sakaguchi Y, Nimura A, Yokoyama A, et al. Higher chondrogenic potential of fibrous synovium- and adipose synovium-derived cells compared with subcutaneous fat-derived cells: distinguishing properties of mesenchymal stem cells in humans. Arthritis Rheum 2006;54:843-53.
47. Kouroupis D, Bowles AC, Willman MA, Perucca Orfei C, Colombini A, et al. Infrapatellar fat pad-derived MSC response to inflammation and fibrosis induces an immunomodulatory phenotype involving CD10-mediated Substance P degradation. Sci Rep 2019;9:10864.
48. Centeno CJ, Busse D, Kisiday J, Keohan C, Freeman M, et al. Regeneration of meniscus cartilage in a knee treated with percutaneously implanted autologous mesenchymal stem cells. Med Hypotheses 2008;71:900-8.
49. Davatchi F, Abdollahi BS, Mohyeddin M, Shahram F, Nikbin B. Mesenchymal stem cell therapy for knee osteoarthritis. Preliminary report of four patients. Int J Rheum Dis 2011;14:211-5.
50. Davatchi F, Abdollahi BS, Mohyeddin M, Nikbin B. Mesenchymal stem cell therapy for knee osteoarthritis: 5 years follow-up of three patients. Int J Rheum Dis 2016;19:219-25.
51. Orozco L, Munar A, Soler R, Alberca M, Soler F, et al. Treatment of knee osteoarthritis with autologous mesenchymal stem cells: two-year follow-up results. Transplantation 2014;97:e66-8.
52. Soler R, Orozco L, Munar A, Huguet M, Lopez R, et al. Final results of a phase I-II trial using ex vivo expanded autologous mesenchymal stromal cells for the treatment of osteoarthritis of the knee confirming safety and suggesting cartilage regeneration. Knee 2016;23:647-54.
53. Chahal J, Gómez-Aristizábal A, Shestopaloff K, Bhatt S, Chaboureau A, et al. Bone marrow mesenchymal stromal cell treatment in patients with osteoarthritis results in overall improvement in pain and symptoms and reduces synovial inflammation. Stem Cells Transl Med 2019;8:746-57.
54. Fodor PB, Paulseth SG. Adipose derived stromal cell (ADSC) injections for pain management of osteoarthritis in the human knee joint. Aesthet Surg J 2016;36:229-36.
55. Yokota N, Hattori M, Ohtsuru T, Otsuji M, Lyman S, et al. Comparative clinical outcomes after intra-articular injection with adipose-derived cultured stem cells or noncultured stromal vascular fraction for the treatment of knee osteoarthritis. Am J Sports Med 2019;47:2577-83.
56. Pers YM, Rackwitz L, Ferreira R, Pullig O, Delfour C, et al. ADIPOA Consortium. Adipose mesenchymal stromal cell-based therapy for severe osteoarthritis of theknee: a phase I dose-escalation trial. Stem Cells Transl Med 2016;5:847-56.
57. Lee WS, Kim HJ, Kim KI, Kim GB, Jin W. Intra-articular injection of autologous adipose tissue-derived mesenchymal stem cells for the treatment of knee osteoarthritis: a phase IIb, randomized, placebo-controlled clinical trial. Stem Cells Transl Med 2019;8:504-11.
58. Lu L, Dai C, Zhang Z, Du H, Li S, et al. Treatment of knee osteoarthritis with intra-articular injection of autologous adipose-derived mesenchymal progenitor cells: a prospective, randomized, double-blind, active-controlled, phase IIb clinical trial. Stem Cell Res Ther 2019;10:143.
59. Chuckpaiwong B, Charles HC, Kraus VB, Guilak F, Nunley JA. Age-associated increases in the size of the infrapatellar fat pad in knee osteoarthritis as measured by 3T MRI. J Orthop Res 2010;28:1149-54.
60. Koh YG, Choi YJ. Infrapatellar fat pad-derived mesenchymal stem cell therapy for knee osteoarthritis. Knee 2012;19:902-7.
61. do Amaral R, Almeida HV, Kelly DJ, O’Brien FJ, Kearney CJ. Infrapatellar fat pad stem cells: from developmental biology to cell therapy. Stem Cells Int 2017;2017:6843727.
62. Toghraie FS, Chenari N, Gholipour MA, Faghih Z, Torabinejad S, et al. Treatment of osteoarthritis with infrapatellar fat pad derived mesenchymal stem cells in Rabbit. Knee 2011;18:71-5.
63. Koh YG, Jo SB, Kwon OR, Suh DS, Lee SW, et al. Mesenchymal stem cell injections improve symptoms of knee osteoarthritis. Arthroscopy 2013;29:748-55.
64. Spasovski D, Spasovski V, Bascarevic Z, Stojiljkovic M, Vreca M, et al. Intra-articular injection of autologous adipose-derived mesenchymal stem cells in the treatment of knee osteoarthritis. J Gene Med 2018;20:e3002.
65. Wakitani S, Imoto K, Yamamoto T, Saito M, Murata N, et al. Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthritis Cartilage 2002;10:199-206.
66. Nejadnik H, Hui JH, Feng Choong EP, Tai BC, Lee EH. Autologous bone marrow-derived mesenchymal stem cells versus autologous chondrocyte implantation: an observational cohort study. Am J Sports Med 2010;38:1110-6.
67. Haleem AM, Singergy AAE, Sabry D, Atta HM, Rashed LA, et al. The clinical use of human culture-expanded autologous bone marrow mesenchymal stem cells transplanted on platelet-rich fibrin glue in the treatment of articular cartilage defects: a pilot study and preliminary results. Cartilage 2010;1:253-61.
68. Teo AQA, Wong KL, Shen L, Lim JY, Toh WS, et al. Equivalent 10-year outcomes after implantation of autologous bone marrow-derived mesenchymal stem cells versus autologous chondrocyte implantation for chondral defects of the knee. Am J Sports Med 2019;47:2881-7.
69. Koga H, Shimaya M, Muneta T, Nimura A, Morito T, et al. Local adherent technique for transplanting mesenchymal stem cells as a potential treatment of cartilage defect. Arthritis Res Ther 2008;10:R84.
70. Sekiya I, Muneta T, Horie M, Koga H. Arthroscopic transplantation of synovial stem cells improves clinical outcomes in knees with cartilage defects. Clin Orthop Relat Res 2015;473:2316-26.
71. Shimomura K, Ando W, Moriguchi Y, Sugita N, Yasui Y, et al. Next generation mesenchymal stem cell (MSC)-based cartilage repair using scaffold-free tissue engineered constructs generated with synovial mesenchymal stem cells. Cartilage 2015;6:13S-29S.
72. Chang CH, Kuo TF, Lin FH, Wang JH, Hsu YM, et al. Tissue engineering-based cartilage repair with mesenchymal stem cells in a porcine model. J Orthop Res 2011;29:1874-80.
73. Chen CC, Liao CH, Wang YH, Hsu YM, Huang SH, et al. Cartilage fragments from osteoarthritic knee promote chondrogenesis of mesenchymal stem cells without exogenous growth factor induction. J Orthop Res 2012;30:393-400.
74. Chang CH, Chen CC, Liao CH, Lin FH, Hsu YM, et al. Human acellular cartilage matrix powders as a biological scaffold for cartilage tissue engineering with synovium-derived mesenchymal stem cells. J Biomed Mater Res A 2014;102:2248-57.
75. Chen CC, Hsiao CY, Wang YH, Chen YC, Chang CH, et al. A comparison of distinct bone marrow-derived cells on cartilage tissue engineering. J Taiwan Inst Chem Eng 2017;78:32-8.
76. Yang YK, Ogando CR, Wang See C, Chang TY, Barabino GA. Changes in phenotype and differentiation potential of human mesenchymal stem cells aging in vitro. Stem Cell Res Ther 2018;9:131.
77. Raynauld JP, Buckland-Wright C, Ward R, Choquette D, Haraoui B, et al. Safety and efficacy of long-term intraarticular steroid injections in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2003;48:370-7.
79. Volz M, Schaumburger J, Frick H, Grifka J, Anders S. A randomized controlled trial demonstrating sustained benefit of Autologous Matrix-Induced Chondrogenesis over microfracture at five years. Int Orthop 2017;41:797-804.
80. Shive MS, Stanish WD, McCormack R, Forriol F, Mohtadi N, et al. BST-CarGel® treatment maintains cartilage repair superiority over microfracture at 5 years in a multicenter randomized controlled trial. Cartilage 2015;6:62-72.
81. Jiang J, Tang A, Ateshian GA, Guo XE, Hung CT, et al. Bioactive stratified polymer ceramic-hydrogel scaffold for integrative osteochondral repair. Ann Biomed Eng 2010;38:2183-96.
82. Chiang H, Liao CJ, Hsieh CH, Shen CY, Huang YY, et al. Clinical feasibility of a novel biphasic osteochondral composite for matrix-associated autologous chondrocyte implantation. Osteoarthritis Cartilage 2013;21:589-98.
83. Xue D, Zheng Q, Zong C, Li Q, Li H, et al. Osteochondral repair using porous poly(lactide-co-glycolide)/nano-hydroxyapatite hybrid scaffolds with undifferentiated mesenchymal stem cells in a rat model. J Biomed Mater Res A 2010;94:259-70.
84. McCarthy HS, Roberts S. A histological comparison of the repair tissue formed when using either Chondrogide® or periosteum during autologous chondrocyte implantation. Osteoarthritis Cartilage 2013;21:2048-57.
85. Schneider U, Rackwitz L, Andereya S, Siebenlist S, Fensky F, et al. A prospective multicenter study on the outcome of type I collagen hydrogel-based autologous chondrocyte implantation (CaReS) for the repair of articular cartilage defects in the knee. Am J Sports Med 2011;39:2558-65.
86. Trattnig S, Pinker K, Krestan C, Plank C, Millington S, et al. Matrix-based autologous chondrocyte implantation for cartilage repair with Hyalograft®C: two-year follow-up by magnetic resonance imaging. Eur J Radiol 2006;57:9-15.
